Enhanced surveillance for childhood hepatitis B virus infection in Canada, 1999-2003
H. X. Wu, A. Andonov, A. Giulivi, N. J. Goedhuis, B. Baptiste, J. Furseth, D. Poliquin, J. IP Chan, G. Bolesnikov, B. Moffat, S. Paton, J. Wu Go to full text

Fast review and publication. Indexed in Medline. Full text in PubMed Central. High exposure on the Internet. Low publication fees. Authors are encouraged to suggest or decline names of reviewers.
Medsci.org

Since hepatitis B virus (HBV) infection can have serious sequelae, especially if infection occurs during childhood, there is a continuing need to examine its epidemiology so as to inform control measures. We analyzed trends in disease incidence and patterns of hepatitis B virus (HBV) transmission in both Canadian-born and non-Canadian-born children from 1999 to 2003, through the Enhanced Hepatitis Strain Surveillance System. Amongst Canadian-born children, the incidence of newly identified HBV infection per 100,000 declined significantly during the study period from 1.4 in 1999, to 0.5 in 2003 (RR, 0.75 per year; 95% CI, 0.60-0.95). Amongst non-Canadian-born children, the incidence of HBV infection per 100,000 ranged from 9.4 to 16.3, during the study period (linear trend test, p=0.69). Poisson regression analysis revealed that non-Canadian-born children were more likely to have HBV infection (RR, 12.3; 95% CI, 7.6 to 19.8), than Canadian-born children. HBV infection was found to be more common among children emigrating from high endemic area, than among Canadian-born children. Current Canadian immunization policy should take into consideration the protection of all children against HBV infection, including those coming from countries where mass hepatitis B vaccination programs have still not been launched.

Retrived on 6 September 2010 16:21:24 CDT